Back to Search
Start Over
Complete Response to S-1 Monotherapy Over 3 Years in an Elderly Patient with Advanced Non-Small-Cell Lung Cancer
- Source :
- 信州医学雑誌. 59(5):321-325
- Publication Year :
- 2011
- Publisher :
- 信州医学会, 2011.
-
Abstract
- The number of elderly patients with cancer continues to increase.The optimal chemotherapeutic regimen for inoperable non-small-cell lung cancer (NSCLC) in elderly patients, especially over 80 years old, remains controversial.S-1,a newly developed oral fluorouracil antitumor drug,has been reported to be effective in the treatment of gastrointestinal and pancreatic tumors and/or NSCLC. We experienced a case of an elderly patient with advanced-stage NSCLC who responded well to S-1 monotherapy with tolerable toxicities and has had three years of disease-free survival. S-1 appears to have significant activity with mild toxicities for selected elderly NSCLC patients and in our view warrants further clinical study. Shinshu Med J 59 : 321-325, 2011<br />Article<br />信州医学雑誌 59(5): 321-325(2011)
- Subjects :
- lung cancer
chemotherapy
elderly
respiratory tract diseases
Subjects
Details
- Language :
- English
- ISSN :
- 00373826
- Volume :
- 59
- Issue :
- 5
- Database :
- OpenAIRE
- Journal :
- 信州医学雑誌
- Accession number :
- edsair.jairo.........7b2bab8aa82f6ff2191e234abfefff8b